Zusammenfassung
Die in der allgemeinen Onkologie übliche Klassifikation nach dem TNM-System ist auf Hirntumore nicht sinnvoll anwendbar. Weitgehend etabliert ist die im wesentlichen auf Zülch und Rubinstein beruhende WHO-Klassifikation [43], die derzeit überarbeitet wird. Neben der primären histopathologischen Typisierung erfolgt ein Grading, das neben histologischen Merkmalen auch klinisch-prognostische Parameter einbezieht, an der sich die therapeutischen Entscheidungen orientieren müssen. Eine weitere Besonderheit ist der häufig fast fließende Übergang zwischen (semi)benignen und (semi)malignen Formen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bamberg M, Hess CF (1992) Radiation therapy of malignant gliomas. Onkologie 15: 178–189
Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R (1981) Ultrarapid high dose irradiation schedules for the palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 7: 1633–1638
Chamberlain M, Levin VA (1993) Primary central nervous lymphoma: A role for chemotherapy. J Neurooncol 14: 271–275
Cianfriglia F, Pompili A, Riccio A, Grassi A (1980) CCNU-Chemotherapy of hemispheric supratentorial glioblastoma multiforme. Cancer 45: 1289–1299
DeAngelis LM, Yahalom J, Thaler HT, Kher U (1992) Combined modality therapy for primary CNS lymphomas. J Clin Oncol 10: 635–643
EORTC Brain Tumor Group (1978) Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma–final evaluation. Europ J Cancer 14: 851–855
EORTC Brain Tumor Group (1983) Misonidazole in radiotherapy of supratentorial malignant gliomas in adult patients: A randomized double blind study. Eur J Cancer Clin Oncol 19: 39–42
Gabbai M, Hochberg FH, Unggood RM, Bashir R, Hotleman K (1989) High-dose methotrexate for non aids primary central nervous lymphoma. J Neurosurg 70: 190–194
Gonzalez DG, Schuster-Uitterhoue ALJ (1983) Primary non-Hodgkin’s lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer 51: 2048–2052
Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, Mealey J. Jr, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Selker RG, Shapiro WR, Smith KR Jr (1983) Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67: 123–132
Helle TL, Britt RH, Colby TC (1984) Primary lymphoma of the cerebral nervous system. Clinicopathological study of experience at Stanford. J Neurosurg 60: 94–103
Henry JM, Heffner RR Jr, Dillard SH et al. (1974) Primary malignant lymphomas of the central nervous system. Cancer 34: 1293–1302
Hochberg FH, Loffler JS, Prados M (1991) The therapy of primary brain lymphoma. J Neurooncol 10: 191–201
Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68: 835–853
Holoye PY, Libnoch JA, Anderson T, Cox JD, Byhardt RW, Hoffmann RG (1985) Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma. Cancer 55: 1436–1445
Jänisch W, Schreiber D, Güthert H (1988) Neuropathologie - Tumore des Nervensystems. Gustav Fischer, Stuttgart New York
Jellinger K (1987) Pathology of Human Intracranial Neoplasia. In: Jellinger K (ed) Therapy of Malignant Brain Tumors. Springer, Wien New York, 1–90
Kleihues P (1988) Tumoren des Nervensystems. Springer, Berlin Heidelberg New York
Kornblith PL, Walker M (1988) Chemotherapy for malignant gliomas. J Neurosurg 68: 1–17
Krauseneck P, Mertens H-G (1987) Results of chemotherapy of malignant brain tumors in adults. In: Jellinger K (ed) Therapy of malignant brain tumors. Springer, Wien, 349–395
Krauseneck P, Müller B, Köpcke W, Messerer D, Aydemir Ü, Kleihues P, Wiestler 0 (1991) Postoperative Strahlen-and Chemotherapie mit BCNU and BCNU+VM26 bei malignen supratentoriellen Gliomen des Erwachsenenalters. Abschlußbericht
Kreuser ED, Herrmann R, Krauseneck P, Mende S, Thiel E (1991) Systemische Therapie zerebraler Metastasen beim Mammakarzinom. DMW 116: 1203–1207
Lee JS, Murphy WK, Glisson BS, Dhingra HM, Holoye PY, Hong WK (1989) Primary chemotherapy of brain metastasis in small-cell lung cancer. J Clin Oncol 7’. 916–922
Mahaley MS Jr (1991) Neuro-oncology index and review (adult primary brain tumors). J Neurooncol 11: 85–147
Mende S, Bleichner F, Stoeter P, Meuret G (1983) Erfolgreiche Behandlung von Hirnmetastasen bei Mamma-Karzinom mit nicht liquorgängigen Zytostatika and Hormonen. Onkologie 6: 58–61
Mundinger F (1987) Stereotactic biopsy and technique of implantation (instillation) of radionuclids. In: Jellinger K (ed) Therapy of malignant brain tumors. Springer, Wien New York, 134–194
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ (1989) Surgical treatment of single brain metastases: A prospective randomized trial (meeting abs ASOC Proc 8: 333
Postmus PE, Haaxma-Reiche H, Slei]fer DT, Kirkpatrick A, McVie JG, Kleisbauer JP, EORTC Lung Cancer Cooperative Group (1989) High dose etoposide for brain metastases of small cell lung cancer — a phase II study. Br J Cancer 59: 254–256
Rosner D, Nemoto T, Pickren J, Lane W (1983) Management of brain metastasis from breast cancer by combination chemotherapy. Neuro-Oncology 2: 2
Rustin GJS, Bagshawe KD, Begent RHJ, Crawford SM (1986) Successful management of metastatic and primary germ cell tumors in the brain. Cancer 57: 2108–2113
Sauer R (1987) Radiation therapy of brain tumors. In: Jellinger K (ed) Therapy of malignant brain tumors. Springer, Wien New York, 195–276
Seier FE, Demuth K, Müller B, Krauseneck P (1991) Chemotherapie von Hirnmetastasen bei Bronchialkarzinomen. Verh der dt Ges f Neurologie 6: 424–425
Shapiro WR, Green SB (1987) Reevaluating the efficacy of infra-arterial BCNU [letter]. J Neurosurg 66: 313–315
Shapiro WR, Green SB, Burger PC, Mahaley MS Jr, Selker RG, Gilder JC van, Robertson JT, Ransohoff J, Mealey J Jr, Strike TA, Pistenmaa DA (1989) Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71: 1–9
Splinter TAW et al. (1984) Preliminary results of a phase II trial of cisplatin and oral VP 16–213 in non small cell lung cancer. Proc 10th ESMO Meeting, Nizza 61 (Abstr)
Stewart DJ, Maroun JA, Hugenholtz H, Benoit B, Girard A, Richard M, Russell N, Huebsch L, Drouin J (1987) Combined intraommaya methotrexate, cytosine-arabinoside, hydrocortisone and thio-TEPA for meningeal involvement of malignancies. J Neurooncol 5: 315–322
Strik H, Müller B, Bogdahn U, Krauseneck P (1992) Management of primary cerebral lymphoma. Cancer Res Clin Oncol 118 (Suppl): R116 (Abstr)
Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozmi T, Matsutani M, Nomura K (1986) Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 53–57
Trojanowski T, Peszynski J, Turowski K, Kaminski S, Goscinski I, Reinfus M, Krzyszkowski T, Pyrich M, Bielawski A, Leszczyk C et al. (1988) Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas. J Neurooncol 6: 285–291
Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Norrell HA, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49: 333–343
Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323–1329
Zülch KJ (1971) Atlas of the histology of brain tumors. Springer, Berlin Heidelberg New York
Zülch KJ (1979) Histological typing of tumours of the central nervous system. WHO, Genf
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Müller, B., Bamberg, M., Krauseneck, P. (1993). Maligne Gehirntumoren. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_28
Download citation
DOI: https://doi.org/10.1007/978-3-662-10495-8_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56872-8
Online ISBN: 978-3-662-10495-8
eBook Packages: Springer Book Archive